FindTrial
Sign In

OUTCOMES OF PATIENTS WITH ORGANOPHOSPHORUS POISOINING

Clinical profiles and factors predicting outcome of patients with organophosphorus poisoning in a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035996
Enrollment
56
Registered
2021-08-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T509- Poisoning by, adverse effect of and underdosing of other and unspecified drugs, medicaments and biological substances

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

SELF DRNIKHILA KAKARLA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age >18years 2) Patients with features of acute cholinergic crisis following H/O exposure to an organophosphorus compound 3) H/O Exposure to op compound within the previous 24 hrs 4)Patients consenting for the study

Exclusion criteria

Exclusion criteria: 1) Patients not consenting for the study are excluded 2) Age 3) Patients with H/0 Neuromuscular junction disorders 5) Patients with chronic lung disorders 6) Patients treated outside for poisoning with atropine 7) Patients presenting 24 hrs after the consumption of poison

Design outcomes

Primary

MeasureTime frame
TO STUDY THE PROGNOSTIC VALUE OF CLINICAL PARAMETERS AS ASSESSED BY PERADENIYA OP POISOINING SCALE IN PREDICTING THE SEVERITY OF OP POISOININGTimepoint: AT THE TIME OF ADMISSION, AFTER 24 HOURS AND AT THE TIME OF DISCHARGE.—

Secondary

MeasureTime frame
TO STUDY THE CLINICAL PROFILE OF OP POISOININGTimepoint: 2 YEARS—

Countries

India

Contacts

Public ContactDR NIKHILA KAKARLA

KMC MANIPAL

weena.stanley@manipal.edu9844111974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026